Medicare Reimbursement Rate Targeted As Culprit For Drug Shortages
This article was originally published in The Pink Sheet Daily
Executive Summary
Shortages of sterile injectables stem in part from changes to Part B reimbursement made in the Medicare Modernization Act in 2003, witnesses at a House hearing argue.